Table 1

Demographic and clinical characteristics at baseline

CGEGp Value
Age (years)62.56 (5.88)61.75 (5.92)0.899
Disease duration (years)6.53 (3.87)6.06 (2.82)0.581
Height (cm)1.56 (0.63)1.58 (0.66)0.253
Weight (kg)72.34 (9.09)72.50 (7.55)0.941
BMI (kg/m2)29.54 (3.42)29.01 (2.83)0.200
VAS for pain (range 0–10 cm)5.48 (1.23)5.63 (1.02)0.619
Lequesne (0–24)14.59 (3.6)15.7 (3.3)0.198
WOMAC (0–96)47.69 (14.7)54.1 (14.2)0.111
SF-36 (0–100)
 Physical functioning28.9 (13.0)35.9 (17.5)0.127
 Role physical22.7 (24.07)23.4 (31.7)0.912
 Bodily pain46.1 (15.3)48.7 (15.1)0.571
 General health57.3 (21.0)49.0 (21.7)0.255
 Vitality38.8 (22.1)40.5 (25.2)0.502
 Social functioning48.8 (20.0)51.7 (22.57)0.405
 Role emotional24.1 (30.6)25.5 (31.9)0.872
 Mental health44.6 (22.6)46.4 (24.7)0.968
  • CG, control group; EG, experimental group; BMI, body mass index; SF-36, short form 36; VAS, visual analogue scale; WOMAC, Western Ontario and McMaster Universities questionnaire.